Vasileva et al., 2021 - Google Patents
Double recombinant vaccinia virus: A candidate drug against human glioblastomaVasileva et al., 2021
View HTML- Document ID
- 3284018004186747260
- Author
- Vasileva N
- Ageenko A
- Dmitrieva M
- Nushtaeva A
- Mishinov S
- Kochneva G
- Richter V
- Kuligina E
- Publication year
- Publication venue
- Life
External Links
Snippet
Glioblastoma is one of the most aggressive brain tumors. Given the poor prognosis of this disease, novel methods for glioblastoma treatment are needed. Virotherapy is one of the most actively developed approaches for cancer therapy today. VV-GMCSF-Lact is a …
- 208000005017 Glioblastoma 0 title abstract description 105
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Koga et al. | Systematic review of patient-derived xenograft models for preclinical studies of anti-cancer drugs in solid tumors | |
| Vasileva et al. | Double recombinant vaccinia virus: A candidate drug against human glioblastoma | |
| Beaumont et al. | Modeling melanoma in vitro and in vivo | |
| Brandenburg et al. | Distinction of microglia and macrophages in glioblastoma: close relatives, different tasks? | |
| Kawaguchi et al. | Efficacy of recombinant methioninase (rMETase) on recalcitrant cancer patient-derived orthotopic xenograft (PDOX) mouse models: A review | |
| Liu et al. | Establishment and characterization of humanized mouse NPC-PDX model for testing immunotherapy | |
| Mowday et al. | Advancing clostridia to clinical trial: past lessons and recent progress | |
| Fiorentzis et al. | The potential use of electrochemotherapy in the treatment of uveal melanoma: In vitro results in 3D tumor cultures and in vivo results in a chick embryo model | |
| Murakami et al. | Efficacy of tumor-targeting Salmonella typhimurium A1-R against malignancies in patient-derived orthotopic xenograft (PDOX) murine models | |
| Jeong et al. | Novel oncolytic virus armed with cancer suicide gene and normal vasculogenic gene for improved anti-tumor activity | |
| Bella et al. | Mouse models of peritoneal carcinomatosis to develop clinical applications | |
| Ibrahim et al. | Angiopoietin1 deficiency in hepatocytes affects the growth of colorectal cancer liver metastases (CRCLM) | |
| Pastorakova et al. | Suicide gene therapy mediated with exosomes produced by mesenchymal stem/stromal cells stably transduced with HSV thymidine kinase | |
| Nakayama et al. | Zebrafish-based screening models for the identification of anti-metastatic drugs | |
| Boetto et al. | Mouse models in meningioma research: a systematic review | |
| Kang et al. | Radiation potentiates monocyte infiltration into tumors by Ninjurin1 expression in endothelial cells | |
| Hepburn et al. | Engineering prostate cancer from induced pluripotent stem cells—new opportunities to develop preclinical tools in prostate and prostate cancer studies | |
| Lu et al. | Tumor-targeted immunotherapy by using primary adipose-derived stem cells and an antigen-specific protein vaccine | |
| Chen et al. | Advanced pediatric diffuse pontine glioma murine models pave the way towards precision medicine | |
| Dmitrieva et al. | Tumor-targeting peptides search strategy for the delivery of therapeutic and diagnostic molecules to tumor cells | |
| Hsieh et al. | Inactivation of APC Induces CD34 upregulation to promote epithelial-mesenchymal transition and cancer stem cell traits in pancreatic cancer | |
| Kurelac et al. | A humanized bone niche model reveals bone tissue preservation upon targeting mitochondrial complex I in pseudo-orthotopic osteosarcoma | |
| Watt et al. | Heterogeneity in pancreatic cancer fibroblasts—tgfβ as a master regulator? | |
| Yan et al. | Targeting endothelial necroptosis disrupts profibrotic endothelial–hepatic stellate cells crosstalk to alleviate liver fibrosis in nonalcoholic steatohepatitis | |
| Jelgersma et al. | How to Target Spinal Metastasis in Experimental Research: An Overview of Currently Used Experimental Mouse Models and Future Prospects |